Search research articles
Contact Us
Filters
Showing results (1-10 of 112) with videos related to
Page
of 12
Sort By:
Epilepsia
|
July 20, 2010
Can we change the course of epilepsy in tuberous sclerosis complex?
Paolo Curatolo, Romina Moavero
Epilepsia
|
October 28, 2010
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis
Paolo Curatolo, Romina Moavero
Expert Review of Neurotherapeutics
|
June 7, 2013
mTOR inhibitors as a new therapeutic option for epilepsy
Paolo Curatolo, Romina Moavero
Nutrients
|
June 2, 2021
Use of Nutraceutical Ingredient Combinations in the Management of Tension-Type Headaches with or without Sleep Disorders
Paolo Curatolo, Romina Moavero
Current Neuropharmacology
|
June 5, 2013
mTOR Inhibitors in Tuberous Sclerosis Complex
Paolo Curatolo, Romina Moavero
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
April 2, 2010
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges
Romina Moavero, Caterina Cerminara, Paolo Curatolo
Journal of Child Neurology
|
March 9, 2010
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment
Paolo Curatolo, Valerio Napolioni, Romina Moavero
Italian Journal of Pediatrics
|
December 24, 2010
The neurobiological basis of ADHD
Paolo Curatolo, Elisa D'Agati, Romina Moavero
Brain & Development
|
November 26, 2008
Recent advances in neurobiology of Tuberous Sclerosis Complex
Valerio Napolioni, Romina Moavero, Paolo Curatolo
Italian Journal of Pediatrics
|
September 19, 2013
Is mTOR inhibition a systemic treatment for tuberous sclerosis?
Romina Moavero, Antonella Coniglio, Francesco Garaci, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 112) with videos related to
Sort By:
Page
of 12
Epilepsia
|
July 20, 2010
Can we change the course of epilepsy in tuberous sclerosis complex?
Paolo Curatolo, Romina Moavero
Epilepsia
|
October 28, 2010
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis
Paolo Curatolo, Romina Moavero
Expert Review of Neurotherapeutics
|
June 7, 2013
mTOR inhibitors as a new therapeutic option for epilepsy
Paolo Curatolo, Romina Moavero
Nutrients
|
June 2, 2021
Use of Nutraceutical Ingredient Combinations in the Management of Tension-Type Headaches with or without Sleep Disorders
Paolo Curatolo, Romina Moavero
Current Neuropharmacology
|
June 5, 2013
mTOR Inhibitors in Tuberous Sclerosis Complex
Paolo Curatolo, Romina Moavero
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
April 2, 2010
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges
Romina Moavero, Caterina Cerminara, Paolo Curatolo
Journal of Child Neurology
|
March 9, 2010
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment
Paolo Curatolo, Valerio Napolioni, Romina Moavero
Italian Journal of Pediatrics
|
December 24, 2010
The neurobiological basis of ADHD
Paolo Curatolo, Elisa D'Agati, Romina Moavero
Brain & Development
|
November 26, 2008
Recent advances in neurobiology of Tuberous Sclerosis Complex
Valerio Napolioni, Romina Moavero, Paolo Curatolo
Italian Journal of Pediatrics
|
September 19, 2013
Is mTOR inhibition a systemic treatment for tuberous sclerosis?
Romina Moavero, Antonella Coniglio, Francesco Garaci, et al.
Page
of 12